Keywords: Alzheimer's Disease, Quantitative Susceptibility mapping
Motivation: Understanding iron accumulation in neurodegenerative diseases, especially in early stages like aMCI, is crucial due to the lack of early biomarkers.
Goal(s): This study primarily aims to monitor changes in iron deposition across different brain regions using QSM, identify regions associated with cognitive function changes, and further investigate sex differences.
Approach: QSM based on strategically acquired gradient echo (STAGE) imaging was used to measure iron levels of aMCI patients and healthy controls, with cognitive assessments via MMSE and Memory_z.
Results: Significant PCC iron deposition in female aMCI patients correlated with cognitive decline before volume alterations, suggesting it as an early biomarker in women.
Impact: PCC iron deposition is a potential early biomarker for cognitive decline in aMCI before volume alterations, with sex-specific differences. This study suggests that gender should be considered in neurodegenerative research, paving the way for tailored diagnostic and therapeutic strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords